| Mrs Donna M Waszewski, RN | |
|
261 Connecticut Dr, Burlington, NJ 08016-4177 | |
| (800) 950-6066 | |
| (800) 698-7206 |
| Full Name | Mrs Donna M Waszewski |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 261 Connecticut Dr, Burlington, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710123070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR12104400 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Donna M Waszewski, RN 239 Adams Ave, Barrington, NJ 08007-1231 Ph: (856) 547-3684 | Mrs Donna M Waszewski, RN 261 Connecticut Dr, Burlington, NJ 08016-4177 Ph: (800) 950-6066 |
News Archive
Survival rates for cancers of the bowel, breast, lung and ovary that were diagnosed between 1995 and 2007 were compared between Australia, Canada, Denmark, Norway, Sweden and the UK. Overall, survival rates improved in all six countries. However, survival was found to be "persistently lower" in Denmark, England, Northern Ireland and Wales. This was particularly the case after the first year of diagnosis and for patients aged 65 and over. In UK cancer survival rates have improved significantly. Breast cancer survival at five years, for example, increased from 74.8% in 1995-9, to 81.6% in 2005-7. Despite this, the UK still has the lowest breast cancer survival rate at five years.
A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.
A physician-scientist at the University of Arizona College of Medicine-Phoenix has developed a new database to ensure that individuals on ketogenic diets to help treat a certain kind of epilepsy are not prescribed potentially life-threatening medications that contain carbohydrates.
Roche announced today that it has filed a direct de novo application to the U.S. Food and Drug Administration for a fully automated Anti-Mullerian (AMH) assay for use on Roche's full portfolio of laboratory analyzers. The determination of AMH is useful for the assessment of ovarian reserve in women presenting to infertility clinics for evaluation in conjunction with other clinical and laboratory findings.
› Verified 8 days ago
Jacqueline Lee Todd, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr Ste 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Constantin Vintilescu, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr, Suite 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Joanne Petit-homme, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr, Suite 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Karen Coley, LPN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr, Suite 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Leonida D. Matibag, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 261 Connecticut Dr Ste 5, Burlington, NJ 08016 Phone: 800-950-6066 | |
Marcia Greyson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 328 High St, Burlington, NJ 08016 Phone: 929-557-9059 | |
Mrs. Esther A Woods-bartels, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1003 Sunset Rd, Burlington, NJ 08016 Phone: 856-520-9875 Fax: 732-510-5976 |